1.
GoggleDocs
@GoggleDocs
Oral semaglutide CV outcomes in T2DM w/eASCVD &/or CKD: SOUL baseline characteristics…
Interesting
26.7% on SGL… twitter.com/i/web/status/1…
Interesting
26.7% on SGL… twitter.com/i/web/status/1…
2.
GoggleDocs
@GoggleDocs
Join me on 19th October!
I am excited to be speaking at Paradigm & discussing recent data!
Sanofi is organisi… twitter.com/i/web/status/1…
I am excited to be speaking at Paradigm & discussing recent data!
Sanofi is organisi… twitter.com/i/web/status/1…
3.
4.
5.
6.
7.
GoggleDocs
@GoggleDocs
FIVE @escardio guidelines which were published in 2022 #ESCCongress:
management of patients with VA & preventi… twitter.com/i/web/status/1…
management of patients with VA & preventi… twitter.com/i/web/status/1…
Retweet of status by @DrRaniKhatib
GoggleDocs
@GoggleDocs
SGLT2 + ACEi in those w/T1DM?
Expected GFR
Oxidative stress markers
Additive BP
Total peripheral resist… twitter.com/i/web/status/1…
Expected GFR
Oxidative stress markers
Additive BP
Total peripheral resist… twitter.com/i/web/status/1…
GoggleDocs
@GoggleDocs
1/2
Q. Does Bariatric Surgery 'obesity-associated' cancers?
Important as now cancer is leading cause of de… twitter.com/i/web/status/1…
Q. Does Bariatric Surgery 'obesity-associated' cancers?
Important as now cancer is leading cause of de… twitter.com/i/web/status/1…
Retweet of status by @drpatrickholmes
GoggleDocs
@GoggleDocs
More evidence that SGLT2i hyperK, this time in heart failure
Empagliflozin reduces:
- K>6.0: HR 0.62 95% CI 0.4… twitter.com/i/web/status/1…
Empagliflozin reduces:
- K>6.0: HR 0.62 95% CI 0.4… twitter.com/i/web/status/1…
Retweet of status by @brendonneuen
GoggleDocs
@GoggleDocs
️ It was amazing to chat with @SummayaMughal at @BBCLeicester about my most recent research on gestational diabet… twitter.com/i/web/status/1…
Retweet of status by @Elpida_Vnz
8.
9.
10.
11.
GoggleDocs
@GoggleDocs
Party started @GoggleDocs pic.twitter.com/gNActPCuOn
GoggleDocs
@GoggleDocs
What should be the first-line METFORMIN or SGLT2i
Data from @AnnalsofIM / @BrighamWomens
ANSWER = SGLT2i
Obse… twitter.com/i/web/status/1…
Data from @AnnalsofIM / @BrighamWomens
ANSWER = SGLT2i
Obse… twitter.com/i/web/status/1…
Retweet of status by @drpatrickholmes
GoggleDocs
@GoggleDocs
Join our 2-part GoggleDocs webinar series (28.04.22 and 05.05.22) with @drsarahjdavies @HannahBeba A discussion o… twitter.com/i/web/status/1…
GoggleDocs
@GoggleDocs
A thread on rapid reduction in HbA1c & the progression of diabetic retinopathy 1/10
‘The benefits of improved g… twitter.com/i/web/status/1…
‘The benefits of improved g… twitter.com/i/web/status/1…
Retweet of status by @beckylt09
...but wait! There's more!
1.
fakhright
@fakhright
astaghfirullah peng.krim guaaaaaaaa..............a *salto sambil solat*
